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Abstract
In utero exposure to maternal obesity increases the offspring’s risk of obesity in later life. We have also previously reported
that offspring of obese rat dams develop hepatic steatosis, mild hyperinsulinemia, and a lipogenic gene signature in the
liver at postnatal day (PND)21. In the current study, we examined systemic and hepatic adaptations in male Sprague-Dawley
offspring from lean and obese dams at PND21. Indirect calorimetry revealed decreases in energy expenditure (p,0.001) and
increases in RER values (p,0.001), which were further exacerbated by high fat diet (45% kcals from fat) consumption
indicating an impaired ability to utilize fatty acids in offspring of obese dams as analyzed by PRCF. Mitochondrial function is
known to be associated with fatty acid oxidation (FAO) in the liver. Several markers of hepatic mitochondrial function were
reduced in offspring of obese dams. These included SIRT3 mRNA (p=0.012) and mitochondrial protein content (p=0.002),
electron transport chain complexes (II, III, and ATPase), and fasting PGC-1a mRNA expression (p,0.001). Moreover, hepatic
LCAD, a SIRT3 target, was not only reduced 2-fold (p,0.001) but was also hyperacetylated in offspring of obese dams
(p,0.005) suggesting decreased hepatic FAO. In conclusion, exposure to maternal obesity contributes to early
perturbations in whole body and liver energy metabolism. Mitochondrial dysfunction may be an underlying event that
reduces hepatic fatty acid oxidation and precedes the development of detrimental obesity associated co-morbidities such
as insulin resistance and NAFLD.
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Introduction
The obesity epidemic continues to worsen worldwide, with the
most alarming increases occurring in children [1]. If the current
trends of childhood obesity continue, it is projected that 60 million
children will be overweight or obese by 2020 worldwide [1].
Obesity in children is not only becoming more prevalent, but is
also beginning at younger ages, even as young as infants (0–11 mo)
[2,3]. Accelerated growth during infancy and perhaps even in utero
programs not only increased susceptibility for obesity in later life,
but also increases the risk of several obesity-related co-morbidities,
such as insulin resistance and cardiovascular disease [4–6]. This
occurrence of early onset obesity suggests that the intrauterine
environment may be contributing to the obesity epidemic through
fetal programming of offspring metabolism and disruption of
energy balance [7,8].
Using a rat model of gestational obesity, we have previously
shown that maternal obesity, at the time of conception, leads to
greater fat mass, increased body fat percentage, and insulin
resistance in the offspring in later life (postnatal day (PND) 130),
and worsens when challenged with a high fat diet (HFD) [9].
Further, indications of metabolic abnormalities in these offspring
are apparent as early as PND21 and include hepatic steatosis, mild
hyperinsulinemia, and a lipogenic gene signature in the liver [10].
It is possible that maternal obesity-induced exposure to elevated
fatty acids in utero leads to a shunting of fatty acids towards
lipogenesis and away from fatty acid oxidation. However, the
precise mechanisms that contribute to increased susceptibility of
offspring from obese dams to develop nonalcoholic fatty liver
disease (NAFLD) in early life, and obesity in later life, remain
poorly understood.
Hepatic mitochondria are of maternal origin, and as such, may
be an important target to consider for investigating metabolic
perturbations in offspring of obese women. Mitochondria are
critical sites of metabolism and are associated with energy sensing.
For example, mitochondrial dysfunction in the liver has been
associated with the development of NAFLD in obese rats, as shown
by: reduced fatty acid oxidation; decreased cytochrome c protein
content in the liver [11,12]; and decreased carnitine palmitoyl-CoA
transferase-1 activity [11]. Moreover, maternal exposure to a high
fat diet prior to conception, and during gestation and lactation, has
been reported to lead to the development of NAFLD and insulin
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mitochondrial electron transport chain activity in mice [14].
Furthermore, mitochondrial dysfunction has been linked to human
patients diagnosed with NAFLD [15].
In the current study, we examined systemic and hepatic
metabolic adaptations in offspring from lean and obese dams at
PND21. First, we studied whether maternal obesity alters energy
expenditure and substrate utilization in offspring using indirect
calorimetry. Second, we sought to determine the role of mito-
chondrial function in offspring by measuring gene expression and
protein content of key mitochondrial markers in the liver. Third, we
investigated fasting-induced changes in hepatic mitochondrial
markers involved in energy status. Our results demonstrate that
offspring from obese rat dams have increased susceptibility to
develop systemic and hepatic energy utilization perturbations that
are mediated, in part, by mitochondrial dysfunction at weaning.
Materials and Methods
Animals and chemicals
Female Sprague-Dawley rats (150–175g) were obtained from
Charles River Laboratories (Wilmington, MA). Animals were
housed in an AAALAC-approved animal facility in a temperature
and light controlled room (12 h light-12 h dark cycle). All
experimental protocols were approved by the Institutional Animal
Care and Use Committee at the University of Arkansas for
Medical Sciences (Protocol # 2971). Unless specified, all chemicals
were obtained from Sigma-Aldrich Chemical Co. (St. Louis, MO).
Experimental protocol
Virgin female Sprague-Dawley rats were intragastrically
cannulated and allowed to recover for 10 d as previously described
[9,16–19]. Rats were fed liquid diets at either 155 kcal/kg
3/4 ? day
(referred to as lean dams) or at 220 kcal/kg
3/4 ? d (40% excess
calories, referred to as obese dams). We have previously
reported body weights and body compositions of lean and obese
dams [9]. Total enteral nutrition (TEN) diets met National
Research Council (NRC) nutrient recommendation and have been
used previously by our group [9,16–22]. Infusion of diets was
carried out for 23 h/d using computer controlled pumps for 3 wk.
Animals had ad libitum access to drinking water and body weights
were measured three times per week. Following 3 wk of over-
feeding to induce obesity in the 220 kcal/kg
3/4 ? d group, lean and
obese rats (N=15/group) were allowed to mate for 1 wk. Each
female rat was housed with one lean breeder male and allowed ad
libitum access to AIN-93G diet during this period. After mating all
female rats (lean and obese) received diets at 220 kcal/kg
3/4 ? d
(NRC recommended caloric intake for pregnancy in rats). All rats
were allowed to give birth naturally. Numbers and sex of pups,
birth weight, and crown-to-rump and anogenital distance were
measured for each pup on PND1 as previously described [9,10].
On PND2, four male and four female pups from each litter were
cross-fostered to lean dams that had been previously time-
impregnated to give birth on the same day as the obese dams
receiving infusion diets. Cross-fostered dams were not cannulated
and had ad libitum access to AIN-93G pelleted diets throughout
lactation. Using this experimental paradigm, we ensured that
offspring’s exposure to any effects of maternal obesity was limited
almost exclusively to the intrauterine environment [9]. Female
offspring of lean and obese dams were used for separate experi-
ments, and only data from male offspring are reported here. Male
offspring were euthanized under anesthesia at PND21 (N=15/
group). In some experiments, animals were sacrificed following a
24 h (9:00 am – 9:00 am) fast. At sacrifice, liver was weighed,
formalin fixed, and immediately frozen in liquid nitrogen and
stored at 270uC for later analyses. Serum was obtained by
centrifugation of blood samples and stored at 220uC.
Indirect calorimetry
Offspring from lean and obese rat dams (N=5/group from
separate litters) at PND21 were housed under conditions of
12:12 h light-dark cycle in metabolic chambers using the Com-
plete Lab Animal Monitoring system (CLAMS) to assess energy
expenditure (EE), respiratory exchange ratio (RER), physical
activity, and food intake (Columbus Instruments, Columbus, OH).
Offspring were housed in the CLAMS chambers from PND20 –
PND51. Rats were acclimated to the metabolic chambers for a
minimum of 7 days while having ad libitum access to the AIN-93G
diet. Rats had ad libitum access to the AIN-93G or high fat diet
(HFD, 45% kcals from fat) throughout the CLAMS measurement
period. Data from 3 consecutive 24-h cycles for both AIN-93G
(PND34 – PND 37) and high fat diet (PND48 – PND51) were
converted into percent relative cumulative frequency (PRCF)
values. Expressing indirect calorimetry data as PRCF has been
shown to discern small changes in EE and RER values that may
be missed by averaging values over 24-h periods [23]. EE was
calculated using a modified Weir equation [24,25]: EE=Calorific
value (CV) ? VO2subject, CV=3.815 + 1.232 ? respiratory exchange
ratio (RER). Physical activity was measured as the total number of
infrared beam breaks in the X, Y, and Z axes during 20 min
intervals. Percent relative cumulative frequency (PRCF) was used to
analyze EE and RER values as previously described [23]. Briefly,
EC50 values were derived following nonlinear regression using 4-
parameter Hill plot.
RNA isolation and Real-time RT-PCR
Total RNA was isolated from liver of offspring at PND21
(N=15/group) using RNeasy mini columns (QIAGEN, Valencia,
CA) including on-column DNase digestion. One microgram of
total RNA was reverse transcribed using IScript cDNA synthesis
kit (BioRad, Hercules, CA). Real-time PCR analysis was per-
formed using itaq SYBR Green Supermix (Biorad, Hercules, CA)
with each sample run in singlet as described previously using an
ABI Prism 7500 instrument [17,22]. Gene specific primers were
designed using Primer Express Software for sirtuins (SIRT) 1, 2, 3,
4, 5, 6, and 7 and peroxisome proliferator-activated receptor
gamma-coactivator (PGC)-1a (Table 1). Relative amounts of
mRNA were quantified using a standard curve run in duplicates
and normalized to the expression of SRP14.
Immunoblotting and Immunoprecipitation
Total lysates from liver tissue was prepared in RIPA buffer
(25 mM Tris-HCl, 150 mM NaCl, 1.0% NP-40, 1.0% deoxy-
cholic acid, 0.1% SDS, 2 mM EDTA) containing 1 mM PMSF
and protease inhibitors (Sigma, St. Louis, MO). Mitochondrial
protein extracts were prepared using a Mitochondrial Isolation Kit
for Tissue (Pierce, Rockford, IL). Quantification of proteins was
performed using BCA assay (Pierce, Rockford, IL). Immunoblot-
ting was performed for oxidative phosphorylation complexes I–V
(MitoSciences, Eugene, OR), PGC-1a (Calbiochem, La Jolla, CA),
SIRT3 (Cell Signaling Technology, Beverly, MA), long chain acyl-
CoA dehydrogenase (LCAD) (gift from Dr. Gerard Vockley,
University of Pittsburgh), and voltage-dependent anion channel-1
(VDAC1) (Abcam, Cambridge, MA) as previously described in
either total liver lysates or extracts from mitochondrial fractions
(N=4–8/group) [26]. Immunoprecipitation was performed using
a commercially available kit (Catch and Release, Millipore,
Billerica, MA). Briefly, 100 mg of protein from pooled liver
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animals) were performed (N=4/group). Following overnight
incubation with LCAD or nonspecific IgG (Santa Cruz Biotech-
nology, Santa Cruz, CA) immune complexes were solubilized in 1
X SDS buffer. Aliquots were resolved using SDS-PAGE and
immunoblotting was performed using acetylated-lysine antibody
(Cell Signaling Technology, Beverly, MA). Detection of immuno-
blots was carried out using HRP-linked secondary antibodies
(Santa Cruz Biotechnology, Santa Cruz, CA) followed by
chemiluminescence (West Pico, Pierce, Rockford, IL). Desito-
metric quantitation of immunoblots was performed using Quantity
One software (BioRad, Hercules, CA).
Statistical Analysis
Data are expressed as means 6 SEM, significance was set at
p,0.05. Differences between offspring of lean and obese dams at
PND21 were determined using two-tailed Student’s t-test.
Differences between offspring of lean and obese dams at PND21
fed a AIN-93G or HFD were analyzed using two-way Analysis of
variance followed by all-pair wise comparisons by Fisher least
significant difference (LSD). Statistical analyses were performed
using SigmaPlot 11.0 software (Systat Software Inc., San Jose,
CA).
Results
Exposure to Maternal Obesity Decreases Energy
Expenditure (EE) and Respiratory Exchange Ratio (RER) in
the Offspring
Significant differences in both EE and RER between offspring
of obese and lean dams which were further exacerbated when
challenged with a high fat diet as shown by the EC50 values in
Figure 1A and 1B. As expected, increases in EE were observed
in both groups in response to the HF diet. However, EE was
reduced in offspring from obese dams on both control (p,0.001,
52.3660.07 vs. 50.9860.05 kcals/day), and high fat diet
(p,0.001, 61.2860.08 vs. 59.2060.12 kcals/day) as compared
to offspring from lean dams. 24-h averaged values showed
increased EE in both offspring groups in response to HF diet
(Figure 1C), but was not sensitive enough to detect the differences
due to maternal obesity as shown by PRCF in Figure 1A. PRCF
analysis also showed differences in RER between offspring groups
and by type of diet. As expected, the HF diet caused RER values
to decline in both the offspring of lean and obese rat dams. On the
AIN-93G diet, RER values of offspring were greater in obese
offspring as compared to lean offspring (0.9660.0004 vs. 0.986
0.0002, p,0.001). When challenged with a high fat diet the
decline in RER was blunted in the offspring from obese dams with
an RER value of 0.9160.0002 vs. 0.9460.0002 in offspring from
lean dams (p,0.001). No differences in average 24 h RER values
(Figure 1D) were observed in offspring of obese dams when fed a
control or HFD. Total activity measures of rats during indirect
calorimetry revealed no effect of maternal obesity in the offspring;
however, both offspring groups showed significantly reduced total
activity when fed a HF diet (Figure 1E). Food intake was also
measured every other day and there were no differences between
offspring due to maternal obesity on either diet (Figure 1F).
Hepatic Sirtuin (SIRT) mRNA Expression is Influenced by
Maternal Obesity
To investigate if changes in EE and RER in offspring of obese
dams were related to sirtuin expression, we examined hepatic
mRNA expression of the sirtuin family (SIRT1, 2, 3, 4, 5, 6, and
7). At PND21 offspring of obese dams showed reduced mRNA
expression of SIRT2 (27%, p=0.052), SIRT3 (43%, p=0.012),
SIRT6 (31%, p=0.013), and SIRT7 (25%, p=0.049) as
compared to lean dam offspring (Figure 2). Differences in
mRNA levels of SIRT1, SIRT4, and SIRT5 between lean and
obese groups did not reach statistical significance.
Mitochondrial Protein Content of SIRT3 and Electron
Transport Chain (ETC) Complexes
Since SIRT3 is primarily localized in the mitochondria and is
critical for fatty acid oxidation, we investigated the levels of SIRT3
protein in mitochondrial extracts. Consistent with gene expression
data, SIRT3 protein levels were also markedly reduced (,3-fold)
in offspring of obese dams (p=0.002) as shown in Figure 3.
Several components of the ETC are highly regulated by
nutritional status (e.g. fasting) through acetylation of key residues
which are downstream targets of SIRT3. Representative blots of
the five electron transport chain complexes are shown in
Figure 4A. Apoprotein levels of complexes II (p=0.001), III
(p=0.012), and ATPase (p=0.031) were reduced by 64%, 63%,
and 42% respectively in the offspring of obese dams as compared
to lean dam offspring (Figure 4B). Decreases in levels of complex
I nearly reached statistical significance (p=0.063) in offspring of
obese dams. To indirectly estimate mitochondrial content we
assessed mRNA levels of mitochondrial transcription factor A
Table 1. Primers Sequences for Real-time RT-PCR Analyses.
Gene Name Forward primer (59-3 9) Reverse primer (59-3 9)
SIRT1 CTGTTTCCTGTGGGATACCTGACT ATCGAACATGGCTTGAGGATCT
SIRT2 TCCACTGGCCTCTATGCAAACT GCAAAGAAGGGTTCTGGATGTT
SIRT3 GGCACTACAGGCCCAATGTC TCTCTCAAGCCCGTCGATGT
SIRT4 TTACAGCGCTTCATTAGCCTTTC CCCACCTTTTCTGACCTGTAGTCT
SIRT5 AGAGCAAGATCTGCCTCACCAT AGCCCCCGAGATGATGACTAT
SIRT6 CCGTCTGGTCATTGTCAACCT GCTTCATGAGCTTGCACATCAC
SIRT7 GGGTCCAGCTTGAAGGTACTGA GTCCACTGCAGGTTCACAATGT
PGC-1a CTACAATGAATGCAGCGGTCTT TGCTCCATGAATTCTCGGTCTT
Gene specific primers were designed using Primer Express
TM Software (Applied Biosystems, Foster city, CA). Real-time PCR reactions were carried out according to
manufacturer’s instructions for 2X SYBR green master mix and monitored on a ABI Prism 7500 sequence detection system (Applied Biosystems, Foster city, CA) as
described under methods. SIRT: sirtuin; PGC-1a: peroxisome proliferator activated receptor-c coactivator-1a.
doi:10.1371/journal.pone.0024068.t001
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between offspring of lean and obese groups (data not shown).
Fasting-Induced SIRT3 and PGC1a mRNA Expression and
Protein Is Blunted in Offspring of Obese Dams
SIRT3 and peroxisome proliferator activated receptor-c
coactivator (PGC)-1a are critical regulators of mitochondrial fatty
acid oxidation that are sensitive to nutritional changes and are
particularly induced by fasting. Since fasting robustly activates
pathways involved in fatty acid mobilization, we utilized this
challenge to discern differences between offspring of lean and
obese dams that may be evident during fasting. In the fed state, we
observed 25% lower SIRT3 mRNA expression in the offspring
from obese dams (p=0.011) as compared to offspring from lean
dams (Figure 5A). As expected, fasting led to increased expression
of SIRT3 mRNA in offspring of lean dams (122%, p,0.001).
However, while still greater than fed controls (p,0.005), the
fasting induction of SIRT3 mRNA in offspring of obese dams was
blunted as compared to the induction that occurred in offspring of
lean dams (p,0.001) indicating a deficit in the key regulators of
fatty acid mobilization (Figure 5A). Protein content of SIRT3 in
the mitochondrial fraction under fed conditions mirrored mRNA
expression in Figure 5B. Trends towards a fasting-induced
increase in SIRT3 protein as compared to the fed state, in
offspring of lean dams, as well as towards reduced SIRT3 protein
in the offspring of obese dams were preserved, consistent with gene
expression data (Figure 5B). However, these differences did not
attain statistical significance. While PGC1a mRNA levels did not
differ between offspring of lean and obese dams under fed
conditions, fasting elevated PGC1a mRNA expression (3.7-fold,
p,0.001) in the offspring of lean dams (Figure 5C). However,
similar to SIRT3 mRNA expression, there was a blunted fasting-
associated increase of PGC1a mRNA expression (2-fold, p,0.001)
in the offspring of obese dams. These findings suggest that basic
transcriptional responses coordinating fasting-associated fatty acid
oxidation are impaired by exposure to maternal obesity, consistent
with the aforementioned phenotypic (fatty liver) and physiological
changes (EE and RER).
Long Chain Acyl-CoA Dehydrogenase (LCAD)
Mitochondrial Protein Content
LCAD is a key enzyme involved in b-oxidation that is highly
regulated by SIRT3. Mitochondrial protein content of LCAD was
Figure 1. Indirect calorimetry of offspring from lean and obese rat dams. (A) EC50 values for energy expenditure (kcal/day) and
(B) Respiratory exchange ratio (RER) as shown by PRCF analysis in the offspring of lean and obese rat dams (N=5 per group) fed either an AIN-93G or
high fat diet (45% kcals from fat) ad libitum. EC50 values were also included as means6SE. Different letter superscripts indicate statistical significance
(p,0.05). (C) 24-hr averaged values of energy expenditure, (D) RER, (E) total activity counts, and (F) food intake are shown from offspring of lean and
obese rat dams (N=5 per group) on either an AIN-93 diet or high fat diet (45% kcals from fat). Values are expressed as means6SE, different letter
superscripts indicate statistical significance (p,0.05).
doi:10.1371/journal.pone.0024068.g001
Figure 2. Hepatic mRNA expression of sirtuin 1-7 from
offspring of lean and obese dams at PND 21. Gene expression
was assessed via real-time RT-PCR (N=7 per group). Values are
expressed as means6SE. Statistical differences were determined using
a Student’s t-test. * indicates p,0.05.
doi:10.1371/journal.pone.0024068.g002
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Figure 6A. Further, we found that maternal obesity led to
hyperacetylation of LCAD indicating reduced deacetylase activity
of SIRT3 (Figure 6B).
Discussion
The precise mechanisms underlying increased susceptibility to
excessive weight gain and adiposity of offspring from obese women
remain unclear. In the present work, we investigated alterations in
hepatic and whole body energy metabolism in the offspring from
lean and obese rat dams at weaning, prior to differences in body
weight or adiposity. Our studies reveal several salient findings.
First, maternal obesity decreased offspring energy expenditure and
favored decreased efficiency to utilize fatty acids as fuel substrate
when offspring were fed either a control (AIN-93G) or high fat diet
(45% kcal from fat) based on heat and RER values. Second, our
results suggest hepatic mitochondrial dysfunction in both fed and
fasted states. This was associated with impaired SIRT3/PGC1a
induction in fasting levels and dysregulation of fatty acid oxidation
and electron transport chain complexes. Together, these findings
suggest impaired nutrient sensing and fuel switching in offspring
from obese dams.
Indirect calorimetric assessments revealed a modest decrease in
energy expenditure in the offspring of obese dams fed either a
control or HFD at weaning (Figure 1A). It has been previously
reported by others that minimal differences in energy balance can
lead to obesity over time [27–29]. The current studies focused
solely on young offspring to ascertain differences in metabolism
prior to divergence in body weight. We did not expect marked
differences in EE between offspring, but sought to determine if
there were subtle, but detectable differences in EE as early as
PND21. It is important to note there were no differences in body
weight or body composition at PND21 between lean and obese
dam offspring [9,10]. However, the decrease in EE seen in obese
dam offspring (Figure 1A) was accompanied by a trend towards
increased body weight gain (40.263.3 g vs. 44.261.7 g, p=0.297,
N=5 per group) on HFD (over 4 d) as compared to lean dam
offspring. Moreover, obvious divergence of body weight in the
offspring does not appear until PND60 [9]. Hence, it is likely that
the offspring have a significant energy imbalance during
adulthood. Together, these current and previous findings suggest
offspring from obese dams are less able to adapt their energy
expenditure in the face of increased caloric intake and are thus
susceptible to obesity. However, we plan to measure EE in adult
offspring of lean and obese dams during divergent weight gain
(PND60) to confirm if changes in EE persist and directly
contribute to the development of obesity. Our data is consistent
with a study by Rising and Lifshitz (2008) that showed decreased
Figure 3. Hepatic SIRT3 mitochondrial protein content of lean
and obese dam offspring. Representative blot and densitometric
quantitation of SIRT3 protein content in the mitochondrial fraction from
livers of offspring of lean and obese dams at PND21 by Western
blotting (N=4 pools representing a total of 8 animals/group). Values
are expressed as means6SE. Statistical differences were determined
using a Student’s t-test. * indicates p,0.05.
doi:10.1371/journal.pone.0024068.g003
Figure 4. Electron transport chain complexes from mitochondrial fractions of livers from offspring of lean and obese dams at PND
21. (A) Representative blots and (B) densitometric quantitation (N=3–4 pools representing a total of 6–8 animals/group). Values are expressed as
means6SE. Statistical differences were determined using a Student’s t-test. * indicates p,0.05.
doi:10.1371/journal.pone.0024068.g004
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compared to infants born to lean mothers [30].
A hallmark of greater reliance on fatty acids as an energy source
(either during fasting or consumption of HF diets) is the lowering
of RER values [31–34]. Offspring from obese dams uniformly
showed small but consistently higher RER values on either control
or HF diets. Both greater de novo lipogenesis and impaired fatty
acid utilization could presumably account for higher RER values
in offspring of obese dams. In a recent report, we demonstrated
that obese dam offspring display hepatic steatosis and a lipogenic
transcriptomic signature associated with greater sterol regulatory
binding protein (SREBP)-1c and lower peroxisome proliferator
activated receptor (PPAR)-a/59-AMP-activated protein kinase
(AMPK) signaling at weaning. The present data from indirect
calorimetry are consistent with our previous report. The dif-
ferences in RER values between lean and obese dam offspring
were greater when challenged with HF diets, suggesting impaired
metabolic flexibility (i.e. to adapt substrate utilization with
substrate availability) [35] (Figure 1B). In the current report,
we focused on examining mechanisms regulating fatty acid
oxidation that may explain this inflexibility. A recent study
conducted in obese adolescents (11–18 yr old) with non-alcoholic
fatty liver disease (NAFLD) reported that hepatic fat accumula-
tion led to decreased reliance on fatty acid oxidation in the fasted
state. This was accompanied by an inability to suppress fatty
acid oxidation (FAO) during an oral glucose tolerance test as
determined by RER values. This impaired capacity to switch
substrate utilization to FAO during fasting and back to car-
bohydrate oxidation when glucose challenged indicates metabolic
inflexibility [36]. Most importantly, impaired FAO was deter-
mined by hepatic fat content and not abdominal adiposity. Hence,
it appears that there is an intricate relationship between hepatic
steatosis and fatty acid oxidation. Consistent with these findings,
offspring from obese dams develop increased liver weight and
hepatic fat accumulation without differences in body weight or
adiposity [10]. Therefore, it is plausible that exposure to maternal
Figure 5. Fasting-induced changes in SIRT3 and PGC-1a mRNA and protein expression of lean and obese dam offspring. (A) SIRT3
mRNA expression, (B) SIRT3 mitochondrial protein content, and (C) PGC-1a mRNA expression in liver from fed and fasted offspring of lean and obese
dams at PND 21 (N=8–15 per group). Representative blot is also shown in FIG 5B for SIRT3 protein content (N=4 per group). Values are expressed as
means6SE, different letter superscripts indicate statistical significance (p,0.05).
doi:10.1371/journal.pone.0024068.g005
Figure 6. Hepatic mitochondrial protein content and acetylation of LCAD of lean and obese dam offspring. (A) Representative blot and
densitometric quantitation of LCAD in the mitochondrial fraction from livers of offspring from lean and obese dams at PND21 by Western blotting
(N=4 pools representing a total of 8 animals/group). (B) Representative blot and densitometric quantitation of acetylated LCAD in the mitochondrial
fraction from fasted livers of offspring at PND21 (N=3 per group). Immunoprecipitation of LCAD was performed in total liver lysates and
immunoblotting was performed using anti-acetylated lysine antibody. Values are expressed as means6SE. Statistical differences were determined
using a Student’s t-test. * indicates p,0.05.
doi:10.1371/journal.pone.0024068.g006
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oxidize fat.
Mitochondria are typically the primary site for FAO, and since
mitochondria are maternally inherited, several models of gesta-
tional programming have focused on changes in this organelle
[13,14,37–41]. Since our model exclusively examines the contri-
bution of maternal obesity, mitochondrial changes may be an
important conduit on how maternal obesity mediates program-
ming of offspring metabolism. Mitochondrial dysfunction is highly
associated with reduced FAO [11,12,14,15]. While we found no
differences in mRNA expression of mitochondrial transcription
factor A (mtTFAM) between offspring of lean and obese dams,
suggesting that mitochondrial numbers may not be affected, our
studies identified several indications of mitochondrial dysfunction,
including lower abundance of oxidative phosphorylation (OX-
PHOS) complexes (Figure 4). In addition to lower amounts of
OXPHOS proteins, the function of the electron transport chain
complexes and other mitochondrial proteins are highly regulated
post-translationally via lysine acetylation [42]. Recent studies have
shown SIRT3, a member of the class III NAD+ dependent
deacetylase family, to be located in the mitochondria and known
to critically regulate OXPHOS in the liver [43,44].
Sirtuins act as energy sensors and regulate metabolic processes
via their deacetylation activity. The sirtuin family consists of seven
isoforms (SIRT1-7) that regulate distinct metabolic pathways in
various cellular locations [45]. SIRT1, 6, and 7 are located in the
nucleus, SIRT2 in the cytosol, and SIRT3, 4, and 5 in the
mitochondria [45]. Our data suggest that maternal obesity affects
the levels of several SIRT isoforms (SIRT2, 3, 6, and 7) in the
offspring liver (Figure 2), suggesting that the SIRT family may
play a role in fetal metabolic programming. We chose to examine
SIRT3 due to its mitochondrial location and lack of change in
mRNA expression in the other mitochondrial located isoforms
(SIRT 4, 5). Further, Lombard et al. found that SIRT4- and
SIRT5-deficient mice did not increase global lysine acetylation in
contrast to SIRT3-deficient mice [46]. Elegant studies in early
mouse embryos and blastocyst also reveal that SIRT3 is
maternally inherited and critical for protection from reactive
oxygen species [47]. Moreover, SIRT3 has been associated with
increasing energy utilization in liver [48], skeletal muscle [49], and
brown fat [50] suggesting a role in increased whole body energy
expenditure and is highly responsive to dietary challenges such as
high fat diet or fasting. Studies also show that SIRT3 mRNA
expression and protein content in the liver are decreased in
response to nutrient excess [44] and increased in response to
fasting [48]. Hence, given the critical roles for SIRT3 in multiple
aspects of fat and energy expenditure, programming of SIRT3
may have important consequences for offspring metabolism.
Utilizing SIRT3-knockout (KO) mice, Hirschey et al. performed
a meticulous study demonstrating the role of SIRT3 in regulating
mitochondrial fatty acid oxidation (FAO) [48]. Increased SIRT3
expression, in response to fasting, induced LCAD via deacetylation
leading to increased FAO in the liver, heart, and brown fat.
Moreover, overexpression of SIRT3 rescued hepatic FAO in the
SIRT3 KO mice. Our results from offspring of obese dams are
analogous to the phenotypic changes observed in the SIRT3 KO
mice (elevated RER, reduced SIRT3 mRNA and protein, and
hyperacetylation of LCAD) would strongly suggest that hepatic
FAO may be reduced in the offspring of obese dams. Further, a
recent study by Kendrick et al. showed that fatty liver is associated
with decreased SIRT3 activity, hyperacetylation of key mitochon-
drial proteins, and impairment of the ETC [44]. These data are
again consistent with previously reported hepatic steatosis and
lipid accumulation in offspring of obese dams at weaning [10].
Deficits in FAO in offspring of obese dams are certainly not
limited to lower SIRT3 and mitochondrial OXPHOS. We
previously reported that carnitine palmitoyl-CoA transferase
(CPT)-1, the rate-limiting enzyme for fatty acid entry into the
mitochondria, is reduced in the offspring of obese dams [10]. This
was associated with a coordinated down-regulation of PPAR-a
regulated genes and reduced phosphorylation of AMPK
Thr172 in
the offspring of obese dams. Phosphorylation of AMPK induces
activation of catabolic processes such as glucose uptake and fatty
acid oxidation [10] and has been shown to be affected in other
models of maternal overnutrition [51–53]. Moreover, SIRT3
appears to regulate AMPK activation as shown in skeletal muscle
[49] and human hepatic cells [54]. Further, Pillai et al. have
recently reported that the regulatory mechanism is via SIRT3
deacetylation and activation of LKB1, an upstream kinase known
to activate AMPK in mice hearts [55]. It is likely that a reduction
in hepatic fatty acid oxidation not only further reinforces
mitochondrial dysfunction, but may also be contributing to the
development of hepatic steatosis observed in the offspring of obese
dams at weaning [10].
Adaptation to fasting requires activation of numerous pathways
that coordinate the mobilization of fatty acids. Upregulation of
PPAR-a is one of the primary drivers in the liver. It has been
previously reported that mice deficient in PPAR-a develop
dramatic hepatic steatosis upon fasting [56–58]. Increases in
pyruvate and nicotinamide adenine dinucleotide (NAD)+ levels
during fasting result in greater enzymatic activity and protein
content of SIRT1 in the nucleus [59,60]. Among its many actions,
SIRT1 activates PGC-1a via deacetylation leading to transcrip-
tional activation of a complement of genes associated with mito-
chondrial biogenesis [61,62], OXPHOS and fatty acid oxidation
[63–65]. Interestingly, it appears that PPAR-a acts upstream
of SIRT1, although the precise mechanisms remain unknown
[60]. SIRT1 also antagonizes lipogenic gene expression, mainly
via SREBP-1. Andenovirus-mediated hepatic overexpression of
SIRT1 in mice during fasting significantly downregulated SREBP-
1c, fatty acid synthase (FASN), and elongation of very long chain
fatty acids (ELOVL)-6 [66]. Offspring of obese dams have greater
lipogenic gene expression via SREBP-1c [10] and while SIRT1
mRNA was not significantly altered in offspring of obese dams, a
more detailed analysis of SIRT1-mediated regulation of lipogen-
esis is certainly warranted. Consistent with our earlier findings on
PPAR-a [10], the current data show that maternal obesity led to
blunted fasting-mediated induction in both SIRT3 and PGC-1a
mRNA expression in the offspring. While the precise crosstalk
between SIRT3 and PGC-1a is still being actively investigated,
SIRT3 promotes the expression of PGC-1a in brown fat [50] and
SIRT3 deficient mice express decreased mRNA levels of PGC-1a
in skeletal muscle [49]. Furthermore, a recent study also showed
that PGC-1a positively regulated SIRT3 gene expression in
myocytes and hepatocytes, via direct recruitment to the SIRT3
promoter via an estrogen receptor-related-a binding site [67].
In conclusion, we have shown that maternal obesity contributes
to early perturbations in whole body and liver energy metabolism
in the offspring at weaning. Decreased expression of SIRT3 and
other key mitochondrial proteins involved in fatty acid oxidation
and OXPHOS suggest mitochondrial dysfunction may precede
more detrimental obesity associated co-morbidities such as insulin
resistance and NAFLD.
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